Loading

Journal of Cancer Biology and Research

Review of Laser in Nanophotonics – A Literature Study for Cellular Mechanism

Case Report | Open Access | Volume 5 | Issue 1

  • 1. Department of Medical Physics, Anna University, India
  • 2. Department of Medical Microbiology, Madras University, India
+ Show More - Show Less
Corresponding Authors
Poorani Gananathan, Department of Medical Physics, Anna University, Chennai, India-600025
ABSTRACT

Laser is a monochromatic, coherent, tunable light source available in different  wavelength, mode and power. Laser is used in diagnosis and therapeutics in  medicine. Photonanotherapy (PNT) is an emerging cancer treatment methodology  involves the combination of light photons and nanoparticles. Basic approach of this  review is defining features of lasers and their breakthrough potential in design  and development of cancer treatment. In this review, types of lasers employed to  different nanoparticles such as gold, carbon, silica and iron oxide nanoparticles in  PNT were discussed. A nanoparticle hit with laser of different wavelength produces  different responses in cells. This review explains the modified nano particle response  and cell death mechanism by laser parameters. PNT creates hyperthermia, photo  ablation, vaporization, carbonization and apoptosis in cells based on nanoparticles  and light source combination. Over these years, cancer-targeting treatment has  been greatly improved by new tools and approaches based on nanotechnology. In  contrary, 66 articles were studied to understand the role of lasers in cancer therapy.  Laser wavelengths ranging from 514 to 980 nm were discussed in this review. Also  we discussed the general principle of intracellular mechanisms, size and shape of  nanoparticles employed for PNT

KEYWORDS

LASER ;Photo Nano therapy ;Nd: YAG ;Photothermal ; Hyperthermia ; Photoablation ; Light Emitting Diode.

CITATION

Gananathan P, Rao AP, Singaravelu G, Manickam E (2017) Review of Laser in Nanophotonics – A Literature Study for Cellular Mechanism. J Cancer Biol Res 5(1): 1094.

ABBREVIATIONS

PDT: Photodynamic Therapy; LASER: Light Amplification and Stimulated Emission of Radiation; LED: Light Emitting Diode; PNT: Photo Nanotherapy; PTT: Photo Thermal Therapy; GNP: Gold Nanoparticles; UV: Ultra Violet; NIR: Near Infra Red

INTRODUCTION

Laser can be used as a pointer against a wall, can drill a hole in a hard metal and efficiently be able to cut diamond. The origin of light for therapy in medicine and surgery can be traced from ancient times [1]. Laser, the acronym for light amplification by the stimulated emission of radiation (LASER), is an optical source that emits photons as a coherent and narrow beam of light. In 1917,Einstein predicted that atoms could be stimulated to emit light using Bohr’s theory of optical resonators. Around 40 years later, Maiman (1960) construct a device to emit radiation in the visible region of the spectrum. Within a year, visible laser being developed and the first medical application were reported in ophthalmology for treatment of an eye tumor [2]. From there, the application of lasers in medicine has progressed rapidly. Laser is a primary component in various spectroscopes and microscopes. In spectroscopy, laser is used in Raman spectroscopy, optical coherent tomography (OCT), acoustic spectroscopy, transient absorption spectroscopy, particle size analyzer (PSA), fluorescence life time studies; in microscopy, laser is used in confocal microscopy, laser-scanning microscopy and in fluorescence laser scanning microscopy (FLSM). Laser is a major tool for precise diagnosis and scanning of cells and tissues noninvasively. In cancer therapy, laser based treatment methodology is not universal as in diagnosis and research groups, physicians were applying varying parameters.

Laser has the characteristics of monochromatic, coherence, and collimation [3]. These properties provide a narrow beam of high intensity light, which transmits deep down into the target tissue with minimal power loss and great precision [4]. Laser usage reported for tumor eradication in 1965 followed by wide interest in late 1970s. Laser is available in Ultra violet and Visible (UV-Visible) and Near Infra Red (NIR) wavelength range. Commonly used lasers in medicine are Argon ion laser, Nd: YAG and Carbon dioxide laser [6]. Argon laser sends a very high electric charge through argon gas whereas CO2 laser known as surgical knife emits 10.6-μm wavelengths used in surgery. Nd: YAG laser can penetrate deeply within tissue and emits 1064 nm, 532 nm, 355 nm and 266 nm. Ti: Sapphire is a tunable NIR laser with wavelength ranging from 650 nm to 1100 nm [7]. Types of laser and their penetration depth in human skin were detailed in figure (1).

 Lasers of UV-Vis -NIR wavelength and CO2 b. Penetration depth of laser in layers of skin

Figure 1 Lasers of UV-Vis -NIR wavelength and CO2 b. Penetration depth of laser in layers of skin.

Photo therapy

In cancer therapy, laser is used in phototherapy, low-level laser therapy (LLLT), photodynamic therapy (PDT), photo thermal therapy (PTT) and plasmonic photothermal therapy (PPTT) [8]. Phototherapy began in Ancient Egypt, Greece and India but disappeared for many centuries and was rediscovered at the beginning of the twentieth century [1]. Long ago, it was thought that sunlight was the only aspect in the cure of disorders such as skin cancer and this treatment process is known as phototherapy. As science advanced, it is understood that, there were endogenous substances of the system involved in light therapy, which absorbs light rays leads to the therapeutic responses [9]. Photodynamic therapy (PDT) is a technology that uses a photosensitizer that is activated upon exposure to visible or near infrared (NIR) light, and transfers energy to molecular oxygen, thereby generating reactive oxygen species (e.g., singlet oxygen, free radicals, peroxides), which kills cancer cells [5]. PDT uses photosensitizers in combination with light source to treat premalignant and malignant conditions and conventional photosensitizers have their own side effects. To overcome the disadvantages of photosensitizers, nanoparticles replaces photosensitizers for the last two decades and changes the face of photodynamic therapy. In PDT photosensitizers show both necrosis and apoptotic pathway for cellular destruction through PDT and the balance between these two mechanisms being dependent upon photosensitizers [10]. Whereas in photonanotherapy, range of parameters include light-dose, the concentration of photosensitizer, post-irradiation time, cell type, its genetic and metabolic potential, the nature of the photosensitizer and its sub-cellular localization are need to be explored. This review focuses on significance of laser parameters in photonanotherapy. Invention of laser in 19th century paves a new way for the healing power of light.

In photo nano therapy, nanoparticle and laser parameters such as size, shape, laser fluency and mode (continuous wave (CW)/pulsed) determines the cellular mechanism. By binding nanoparticles to targeted cells and by localizing energy deposition into the particles, selective cell damage can be achieved without affecting neighboring cells [11]. Laser and nanoparticles has the potential to offer solutions to the current obstacles in cancer therapy. Nanoparticles were chosen based on size, shape, nontoxicity, binding efficiency, stability, excretion and clearance period from the system.Nanoparticles meets the above criteria, and also have to match laser source, which make the treatment procedure more challenging. For the past two decades, hundreds of nanoparticles with various size and shapes were synthesized however the lasers available only in few wavelengths.In photosensitizer-mediated cancer therapy the laser fluency required for cell lethality (0.5 J/cm2 ) is moderate compared to the fluency used in clinical treatment of pigmented skin lesions (up to 5 J/cm2 ).

In photo thermal therapy nanoparticles such as gold nanoparticles convert optical energy to thermal energy through surface plasmon resonance; Nanoparticles were designed and synthesized based on laser wavelength; which also restricts the application of nanoparticles. In PNT, mode of cell death varies viz., hyperthermia, apoptosis, micro bubble formation, photo thermal ablation, nano bubble generation, mechanical and acoustic damage to the membranes, membrane blebbing, Deoxy Ribo Nucleic Acid (DNA) damage etc., (Figure 2).

2 Diagramatic representation of nanoparticles and cellular mechanism involved in photonanotherapy

Figure 2 Diagramatic representation of nanoparticles and cellular mechanism involved in photonanotherapy.

The events that take place after the absorption of the laser pulse energy by small particles depend on the size of the absorber and the duration of laser exposure [11]. Laser with long pulses that exceed the thermal relaxation time (tr) of the target molecule i.e nanoparticle, cause heating of both the particle and the surrounding media as heat diffuses across the boundary. If the laser pulse duration is equal to or less than tr then the energy can be thermally confined within the target, causing rapid heating of the nanoparticle itself [12].

Bubble formation and vaporization: The extreme temperature rise can induce explosive vaporization of a thin layer of fluid in contact with the nanoparticle, creating a vapor bubble that expands rapidly, on the nanosecond timescale as the initial high vapor pressure overcomes the surface tension of the fluid. The lifetime of the bubble is a function of its size at maximal expansion [13].

What is Nano bubble formation?: Nano bubbles are generated by laser heated plasmonic nanoparticles. Nano bubble maximal size and lifetime are to a large extent controlled by the ballistic thermal flux, which is present inside the bubble. Laser pulse duration influences, the number of nano bubbles generated and their maximal size [14].

Hyperthermia: Small increases in local temperature are known to result in disruption of nuclear and cytoskeletal assemblies and membrane blebbing under hyper thermic conditions. Because of their rapid metabolic rates, tumor cells are regarded as increasingly vulnerable to hyperthermia effects such as disruption of metabolic signaling processes, protein denaturation, and the onset of acidosis or apoptosis caused by the production of heat-shock proteins and other immunostimulants [15].

Thermal explosion: There are two main physical mechanism that could lead to explosion of metal nanoparticles particularly GNPs. Thermal explosion mode through electron phonon excitation relaxation and coulomb explosion mode through multiphoton ionization. The mechanical and optical properties of the bubble are determined by its maximal diameter. This in turn depends upon optical energy being absorbed and converted into heat by the plasmonic Nanoparticles [16].

Cell ablation: The cell ablation was an immediate mechanical, not thermal phenomenon [17]. Apoptosis is a programmed cell death and necrosis is an accidental cell death mechanism.

Lasers and nanoparticles are more efficient, target specific and harmless to the surrounding healthy cells. The idea of writing this review article came from my research work in cancer treatment using low power laser and gold nanoparticles. In the work, MDCK cells were incubated with gold nanoparticles and irradiated with low power Nd: YLF laser and observed for 72 hours. Initially, laser focus on 1 mm spot size in a 10 mm cell culture well plate and quantified with MTT assay, the results were not accurate.

After PPT, MTT assay was performed in adherent cells and the post irradiation changes were observed microscopically. The results show more accumulation of formazan crystals in laser irradiated spot 4 hours after irradiation. Gold nanoparticles and low power laser not induced photo thermal effect in MDCK cells, whereas produce delayed apoptosis instead of thermal effect. While exploring the role of laser parameters, cancer therapy will get advanced well.

DISCUSSION

Laser parameters and cellular response along with details over the cell lines were listed in table 1.

Table 1: Laser and nanoparticles in  in vitro cell lines and mechanism of photo nanotherapy.

S.Noa

Laser

Wavelength

Laser mode

Energy

Cell line/ In vivo

Nanoparticles

Size

Nanophotonic effect of laser in cells

Reference

1

514 nm

CW

25 and 19 W/ cm2 -Malignant/57 W/ cm2 for benign

Breast cancer cell line (HS578T) / HSC 3 and HOC 313 clone 8 cells/HaCaT

Anti EGFR Coated gold nanoparticles

40nm

Hyperthermia/Photothermal Therapy

[18]

2

530 nm

ns-pulsed

7 W/cm2,

Ductal carcinoma cells (ATCC: Hs 578T),
normal cell line 3T3
Hs578T

Transferrin-conjugated gold nanoparticles

24.7, 44.8 and 50.5 nm
1.3

Thermal energy. The process involves electron–phonon relaxation in the nanoparticles followed by phonon–phonon relaxation, resulting in an increase in the temperature of the cells [26].

[19]

3

532 nm&700-850 nm

CW

200mW

-

Gold nanoparticles

15,30,60,100

Thermal Energy -GNR undergoes melting and shape change when subjected to ultra-short (such as femtosecond or nanosecond) laser pulses.

[20]

4

532 nm

CW

0.5, 0.7, and 1.0 W/ cm2

CCRF-CEM cells

Dox:hp-Au NP complex
hybrid multi- yolk-shell Au-Ag@a-C:H

13 nm

Au NPs absorb laser light, convert it to heat, and then dissipate heat energy to the surroundings, leading to a gradual release of Dox molecules.

[21]

5

532 nm

Pulsed

120 mJ/cm2

MCF7,U87

Au-SNP

2 nm

Laser-induced micro bubble-generation

[22]

6

532 nm

_

1.2 J/cm2

MDA-MB-231

Mesoporous silica nanoparticles (MSNs) with Pd-porphyrins

100 nm

 Cell death mainly caused via necrosis.

[23]

7

632.8 nm/NIR laser

_

~30 mW/cm2 for 10 min.

MGC 803 cells stomach cancer

Folic Acid-conjugated Graphene Oxide loaded Ce6
FA-GO-Ce6

<50 nm

The FA-GO-ce6 was endocytosed into cytoplasm and formed endosomes via the folate receptors mediated pathway; (2) When the endosomes were gradually turned into lysosomes, Ce6 was released from FA-GO-Ce6 due to the change of microenvironment in lysosomes (pH 4~5); (3) the released Ce6 got away from the lysosomes into the cytosol. Subsequently, the photodynamic efficacy was achieved upon irradiation of appropriate wavelength and dosage.

[24]

8

CW

637 mW

 

4T1 murine mammary tumor cell line in BALB/c mice

Multi-dye theranostic silica nanoparticles

 

Photothermal ablative therapy and tumor necrosis.

[25]

9

647 nm

Dye laser pumped with Ar Ion Laser

3.2 mW/ cm2

MDA-MB-435 and 9L cells

Multifunctional Biodegradable Polyacrylamide nanocarriers

44 nm

Multifunctional NPs containing both fluorophores and PS drugs, as well as tumor-targeting moieties, did give bright fluorescence images of specific tumor cells and also generated singlet oxygen, only upon light irradiation, resulting in an irreversible but selective destruction of the cancer cells

[26]

10

Diode laser
660 nm

CW

13 W/ cm2

HeLa cells
B16 F10
NIH 3T3 cells

Super Gold Nanoparticles
pH Sensitive

10 nm

Photothermal efficiency with very low fluency

[27]

11

665 nm

Dye pumped Ar Ion Laser

75 mW/ cm2

BALB/cAnNCr mice with Colon26 c

Photosensitizers Into poly acrylamide nanoparticles

29 ±3 nm

 Generate singlet oxygen upon light irradiation, which resulted in irreversible destruction of cells.

[28]

12


665 nm

Dye laser pumped with Ar Ion Laser

3.2 mW/ cm2 (0.125-8.0 J)

Colon-26 and RIF-1 cell lines

Organically modified silica (ORMOSIL) nanoparticles

∼20 nm

PS generate cytotoxic singlet oxygen molecules upon photoirradiation

[29]

13

670 nm

CW

3 W/ cm2

Murine renal cancer cell line/RENCA

Single wall carbon nanohorns

50–100 nm

Hyperthermia /SWNHs could be used in clinical applications to treat superficial tumors

[30]

14


670 nm 9

Pulsed

25 micro watt

MDA-MB231 human breast cancer cells /Athymic nude mice

CPT-HGC

254 nm
288 nm

Tumor apoptosis

[31]

15

671 nm

CW

~2 W/ cm2 for 3 min.

MDA-MB-435

Photosensitizer-Loaded Gold Vesicles

50-150 nm

Photoablation

[32]

16

671 nm

CW

200mW

HeLa cells

Silica coated Gold nanorods

Aspect Ratio 3±0.2 /3   nm silica coating

Hyperthermia induced apoptosis

[33]

17

671 nm

CW

2W/ cm2

MDA-MB-435 tumor bearing mice,A549

GNS-PEG-Ce /Gold nanostars

78.0 ± 2.9 nm

Photothermal ablation

[34]

18

690 nm

CW

38 W/ cm2

 

Gold nanoparticles 

 

Necrosis

[35]

19

671 nm

_

~2 W/ cm2for 1 min

MDA-MB-435

Photosensitizer-Conjugated Silica-Coated Gold Nanoclusters /AuNCs@SiO2-Ce6

_

Photothermal ablation temperature  increased up to 43 C causes protein denaturation and necrosis of the cells through lysis or rupture of cell membranes.

[36]

20

671 nm  (diode-pumped solid-state laser system)

_

90 J/ cm2, 75 mW/ cm2
2-8mW/ cm2

e 4T1 murine Breast cancer cell line

Nano-Graphene /GO-PEG-HPPH

< 50 nm

 Endocytosis: Mechanism of cytotoxicity was through photo dynamic action
PDT with GO-PEG-HPPH significantly decreased the oxgen saturation of tumors, which can be evaluated by PAI.

[37]

21

671 nm

pulsed

220 mW/ cm2

HT-29 tumor-bearing mice

HGC-Ce6 and GC-Ce6 /Mice

300 to 350 nm

Ce6s in the HGC-Ce6 can generate singlet oxygen at target cellular organelles such as mitochondria showed severe phototoxicity

[38]

22

690 nm

 

1.84 mW cm−1 for 10 min.

HeLa cells


Phthalocyanine-nanoparticle conjugate

2-4 nm

The cells show the presence of blebs and vacuoles and are indicative of cell mortality possibly induced by apoptosis.Further evidence of apoptosis was provided through the bioluminescent assay detection of caspase 3/7.

[39]

23

690 nm

CW

38 W/ cm2

HER2 positive SKOV3, HER2 negative CHO

Branched gold nanoparticles bind to HER2 antigen

60 nm

Photothermal therapy by hyperthermia induced cell death.

[40]

24

730 to 870 nm /NIR FS Laser

Ultra fast Pulsed laser

100 mJ cm2/
27.8 W cm2

HeLa cells

Transferrin conjugated Gold nanorods.

aspect ratio of 4.0

Necrosis

[41]

25

775 nm

Pulsed

1 to 20 W/ cm2

HeLa cells

SiNc4 onto MFG  via pep stacking to yield MFGeSiNc4

 

Apoptosis by Singlet oxygen/Combined PDT and PTT

[42]

26

785 nm

_

2.4 W/ cm2

Her 2/SKBR3

Au/Magnetic

670 nm

laser ablation into heat

[43]

27

785 nm

CW OEM Laser

1.5 W/ cm2

MDA-MB
SK-BR-3&
HER2/c-erb-2/Neu

Gold Nano Popcorn attached SWCNT

_

Photothermal ablation

[44]

28

790 nm

Pulsed

85.5 pJ / pulse 300 s

Hela Cells

Hypericin loaded Gold Nanocages

45 nm

Photothermal ablation and necrosis /PDT and PTT

[45]

29


808 nm (diode laser)

CW

8.5 × 104 W/m2

CCRF-CEM cells
NB4 cells, HeLa cells

Aptamer-Conjugated Au-Ag Nanorods

14 nm width,  53 nm length

 Mechanical and acoustic damage to the membranes

[46]

30

808 nm

CW

0.5 W/ cm2

U87MG with EGFR human glioblastoma cell /
tumor-bearing mice

PEG coated Gold nanocages

48±3.5

Photothermal therapy with cogulative necrosis

[47]

31

808 nm

CW

2mJ/ cm2/pulse

in vivo/rat

Nano-rGO

0.8-1.2 nm

Photothermal ablation/These data indicated that the apoptosis and death of cancer cell caused by the PT effect mediated by nano-rGO

[48]

32

808 nm

CW/fs

4 W/ cm2

in vivo/Mice

Gold Nanorods

3.8 to 6.7

Photothermal

[49]

33

808 nm

CW

5W/1.2W

Human brain astrocytoma cells (1321N1; ECACC 86030402)

Gold nanorods

 


Photothermal ablation

[50]

34

808 nm

CW

0.9–1.1 W/ cm2 w

HSC-3 human squamous carcinoma cells

PEGlated Gold nanorods

4.0 aspect ratio

Hyperthermia indicate membrane blebbing

[51]

35

808 nm

CW

2 W cm2

H22 tumor in mice

Bismuth selenide
Bi2Se3 nanoplates

90 nm

Hyperthermia

[52]

36

808 nm

CW

1.4 W/ cm2

PC3 human prostate cancer cell line and S180 mouse ascites tumor cells


SWNT- NGR-DTX

182.8 ± 2.8 nm

Photo thermal ablation

[53]

37

808 nm

 

15.3 W/ cm2

Human Saos-2 osteoblasts, murine L929 fibroblasts, murine RAW-264.7 macrophages and murine MC3T3-E1 pre- osteoblasts

NANO-GO

 

Microbubbling can be induced by irradiation

[54]

38

800 nm

CW

80 W/ cm2

Human prostate carcinoma cells (PC3, ATCC; Manassas, VA)

Gold / Gold Sulfide Nanoparticles

35-55 nm

Photothermal ablation

[55]

39

808nm

CW

0.6 W/ cm2

BALB/c miced with  4T1 tumor

Carbon Nanotubes/AuNR

140 nm

Highly effective tumor elimination with SWNTs was achieved at 10 times lower injected doses and lower irradiation powers than for AuNRs. Hyperthermia

[56]

40

808 nm

_

1 W/ cm2

Murine breast cancer 4T1 and human embryonic kidney 293T/ Balb/ c mice

Organic PEDOT:PSS-PEG. -poly(3,4- ethylenedioxythiophene):poly(4-styrene- sulfonate) (PEDOT:PSS),

80 nm

Photothermal ablation of cancer.

[57

41

808 nm

CW

2 W/ cm2

Mice/EMT6 cells

Doxorubicin-loaded PEGylated nanographene oxide

100 nm

Photothermal ablation

[58]

42

808 nm

CW

1.5 W  cm2

 Nude mice bearing HT-29 tumors/Hela Cells

Au NPs coated with Prussian blue (PB)

18 nm

Localized tumor photohyperthermic effect

[59]

43

808 nm

_

2 W/ cm2

balb/c mice with 4T1 r tumors, nude mice bearing KB tumors, and U87MG tumors

NGS- PEG

30 nm

Photothermal

[60]

44

808 nm

CW

_

Human prostate cancer cells (PC-3)

Silica and Gold Nanoparticles

 

Hyperthermia

[61]

45

808 nm

 

35 W/ cm2

MCF-7 tumor-bearing BALB/c nude mouse

Targeting Gold Nanoshells on Silica Nanorattles

158 nm to 185 nm

Thermal ablation

[62]

46

808 nm

 

1 W/ cm2

KB cells

Single-layer MoS2 nanosheets

 

 

[63]

47

808 nm

CW

24 W/ cm2

HeLa cells,HEK293

Copper sulfide nanoparticles

3 nm

Photothermal ablation

[64]

48

670 nm/
 808 nm

 

1.5 W/ cm2

Murine colon cancer cell lines (CT-26)

Porous silicon nanoparticles

80-220 nm

The cell deaths were mostly due to necrosis but partly due to late apoptosis.

[65]

49

800 nm

CW

20 W/ cm2

Human prostate cancer cell line PC3-PSMA

Gold Nanorods

 

Hyperthermia

[66]

50

800 nm

CW

40,60,80,120,160,200

mW

HOC,HaCat,HSC

Anti-EGFR/Au Nanorod Conjugates.

aspect Ratio 3.9

Photothermal therapy

[67]

51

800 nm

Pulsed

~ 30 mW
18 mJ/ cm2

EMT-6

FePt NP

12+1 nm

Photothermolysis

[68]

52

800 nm

 

7 W

Human prostate carcinoma cells/(PC3)

Gold / gold sulfide nanoparticles

35–55 nm

Photothermal Ablation

[69]

53

800 nm

Pulsed

4.77 W/ cm2 / 5 min

SK-BR-3 cells

Immuno gold nannocages

65 ± 7 nm

Photothermal effect

[70]

54

810 nm

CW

8.16 W/ cm2

Cal-27 (Human oral squamous cell carcinoma cell line, CRL-2095, ATCC)

Rose-bengal-conjugated gold nanorods

13.2 nm and 52. 4 nm,

Photodynamic and Photothermal.It has been reported that apoptosis may be the preferred mechanism of cell death induced by RB mediated PDT

[71]

55

820 nm

Pulsed

15–40 mJ/ cm2

 HN31,co-cultured with normal epithelial NOM9 cells

 Plasmonic nanobubbles

13 .2 nm and 52 ` 4 nm,

Plasmonic nanobubble-enhanced endosomal escape

[72]

56

820 nm

Pulsed

40 mJ  cm2

OCSCC

Chemotherapy with PNBs

_

Photodynamic and Photothermal

[73]

57

820 nm

Pulsed

15 W/ cm2

A431,
MCF 7

Drug-Loaded Polymer Gold Nanoshells

_

Localized photothermal treatment by NIR laser illumination.

[74]

58

980 nm

_

0.51 W/ cm2

Ex  vivo

Cu9S5 NCs

(Hydrophilic Cu9S5 Nanocrystals)

_

Photothermal ablation

[75]

59

980nm

_

1 W  cm2 for 10 min

EMT6 cells

Single-Walled Carbon Nanotubes

0.81 nm

Mitochondria targeting

[76]

60

980 nm

CW

0.5 W/cm2

In vivo MC 540

NaYe4:YbEr

 

The combination of PDT with chemotherapy also possesses excellent drug loading capability and anticancer efficiency

[77]

61

800 nm

CW

80 mJ cm−2

MDA-MB-231 breast cancer cells

Gold Nanoparticles

30–40 nm

 

[78]

62

550 nm

300 W halogen lamp

25 mW cm-2/22.5 J cm-2

 non-pigmented human melanoma A375 and pigmented mouse melanoma (B16F10) cell lines

Pc4 in Silica Nanoparticles

25-30 nm

 Apoptosis by singlet oxygen (Type II). /Pc4 in silica nanoparticles generated photo-induced singlet oxygen Pc4SNP photodamaged melanoma cells primarily through apoptosis

[79]

63

690 nm

Short single laser pulses

_

C4-2B

Gold Nanoparticles  conjugated with C225 anti-EGFR antibodies

60 nm

Plasmonic nanobubbles produce photoablation.The fast expansion of the vapor bubble has a localized mechanical and non-thermal impact on the environment

[80]

64

800  nm

Pulsed

25mW/0.2 mW

HeLa cells

PEG-NRs and PEG-Tf-NRs.

 

 Membrane blebbing

[81]

65

780 nm

_

24 and 48 W cm−2

A549 cells

Mesoporous silica coated gold nanrodsAu@SiO2

30 nm

Hyperthermal cancer therapy

[82]

66

White light source/ band pass filter (400–700 nm)

_


150 mW/cm2 white light, 1–80 J/cm2

 J774, LLC and CT26

Superparamagnetic iron oxide nanoparticles

_

Monocationic fullerene is a highly effective PS for killing cancer cells by rapid apoptosis

[83]

This review covered 66 articles and the significance of laser was discussed. Laser wavelength ranging from 514 nm to 980 nm was also listed in table 1 based on wavelength of irradiation from lower wavelength to higher. Briefly, 500 nm-550 nm laser were used in 7 articles, 640 nm-690 nm in 16, 775 nm-790 nm in 7groups, 800 nm-820 nm in 32 groups, 980 nm in 3 research groups were listed in table 1. In more than 50 % of articles, 775 nm-820 nm NIR laser is used. 21 % work uses 640-690 nm red lasers. Few research groups use 532 nm green lasers. Red laser and NIR laser were commonly used due to the tissue transparency in therapeutic window region (650 nm-1100 nm). Laser with continuous wave and pulsed mode was used in photo nano therapy. 42% continuous mode and 20 % pulsed laser were used. In ~35% research articles the mode of laser is not mentioned (figure 3).

Statistical distribution of laser, nanoparticle parameters and cell mechanis

Figure 3 Statistical distribution of laser, nanoparticle parameters and cell mechanism.

In photo nano therapy laser power ranging from 0.5 W to 1 W were used. The fluence varies and the mechanism of cell death depends on the mode and fluence rate of laser (Table 1)

The effect of phototherapy was demonstrated by low power laser irradiation at 808 nm with 0.8 W/cm2 to induce efficient photodynamic effect from Indo cyanine green (ICG) dye. The photothermal effect from the ICG and Single wall carbon nanotubes (SWCNTs) rapidly raised tumor temperature to ~55 °C. The temperature rise leads to tumor growth inhibition, tumor cell death andnecrosis [19]. MDA-MB-231 cells, upon exposure to NIR laser of 808 nm and dual drugs (doxorubicin and irinotecan)-loaded GO (grapheme oxide), activates the intrinsic apoptosis pathway and cell ablation [84]. When tumor necrosis factor-alpha coated gold nanospheres (Au-TNF) irradiated with 532 nm and 690 nm, nonlinear photothermal and photoablation phenomena appeared. [86]. Irradiation with external nearinfrared laser (NIR) with PS in mitochondria caused serious mitochondrial matrix swelling for the activated upconversion based photodynamic therapy (UC-PDT). In UC –PDT mobilization of cytochrome c (cyt c) was amplified in response to the increased mitochondrial reactive oxygen species (ROS), causes apoptosis. [88]. For micrometer-sized melanin particles, the temperature for bubble initiation has been estimated to be 140–150°C. Through these studies, NIR laser were used in PNT, ends up with different cell death mechanism against different nanoparticles. In table (1), cell mechanisms involved in PNT with Visible-NIR laser irradiation were addressed in detail.

Laser mechanism could be better understood with gold nanoparticles. In this review 46% of researchers use different form of gold nanoparticles and gold nano conjugates for photo nano therapy. Gold nanoparticles were preferred due to biocompatibility, absorption in visible and NIR region and easy conjugation to biomolecules. Rests of the nanoparticles included in this review are carbon nanotubes (CNT), iron oxide nanoparticles (FeO2 ), silica nanoparticles, porphyrin and chemical conjugates. The sizes of nanoparticles were ranging from 0.8 nm to 100 nm were (Table 1). Conjugates of nanoparticles more than 100 nm were also studied by few research groups [33].

In photonanotherapy the cell death was quantified and very few research articles only deals with cellular mechanism. Instead, GNPs were worked out in detail and the role of laser in nano medicine can better understand with GNPs. GNPs Surface Plasmon Resonance is tunable from 520-1200 nm based on their size and shape. GNPs also release scattering signals, which can be used for imaging. Gold nanorods with 480 nm excitation,emits fluorescence around 550-600 nm and gold nano clusters with 230 nm laser excitation give fluorescence at 440 nm. GNPs excited with 785 nm red laser gives surface enhanced Raman Scattering (SERS) signals (Figure 4).

 Optical and cellular response by gold nanoparticles while hits with range of wavelength

Figure 4 Optical and cellular response by gold nanoparticles while hits with range of wavelength.

In this review, nearly 50% of researchers use GNPs in various forms such as of gold nano spheres (Vis), nanorods (NIR), gold nanoshells, and gold nanocages etc as photosensitizers. The surface electrons create modified response in GNP when hits with laser of different wavelength and power, shown in figure (4). Gold nano spheres when exposed to high power II harmonic 532 nm Nd:YAG laser releases thermal energy and produce cavitation bubble around the nanoparticle [11]. The same gold nano particle creates hyperthermia and delayed apoptosis with diode low power Nd :YLF laser of 532 nm [89]. The cellular responses by GNPs mediated photo nano therapy are photothermia [18- 21,53,54,73,75], hyperthermia [39,56,73], apoptosis [33], membrane blebbing, photo ablation [32,40,46,48,55,60,67,74], micro bubble formation [22,47], necrosis [35,41,48,51] and cell vaporization, listed in table 1. Photothermia leads to increase in temperature in target cell causes cell death and the thermal increase not limited in hyperthermia range.

Pitsillides et al., reported, the photothermal therapy of lymphocytes using GNP immune conjugates coupled with a nanosecond Nd: YAG- pulsed laser II harmonic at 532 nm. Nd: YAG laser induces solvent bubbles around the particles that imposed enough mechanical stress to cause cell destruction [11]. Around the same period, Zharov et al. studied the factors that affect the killing energy, such as the number of pulses. Pitsillides articulate size as well as the dynamics of the thermal events around GNPs were important to understand the killing efficiency and mechanisms involved [16]. Studies by El-Sayed and colleagues demonstrated selective photo thermal therapy in cancer cells by using 40 nm gold nanoparticles conjugated to anti- EGFR antibodies exposed to a visible cw Argon ion laser.In PPT, malignant cells required less than half the laser energy to be killed as compared with the benign cells. In addition, no photothermal destruction was observed for any of the cell types without nanoparticle labeling, even at four times the energy required to kill the malignant cells labeled with anti-EGFR/Au conjugates [62]. Zharov et al investigated bubble formation from nanoparticles. In the work 40-nm-diameter GNS distributed on a cell, 30 pulses of 0.5 J/cm2 or one pulse of 2 J/cm2 resulted in death of all cells. Alternatively, with cluster formations, cell damage occurs after 100 laser pulses at 80 mJ/cm2 [16]. Peng et al., focused on the effects of laser irradiation on particle size and peak absorption wavelength. Peng et al showed that using a Nd:YAG laser and 21-nm spherical gold nanoparticles, the irradiation causes the particles to fragment to an average diameter of 4.9 nm, changing the peak absorption wavelengths. GNPs subjected to irradiation using a nanosecond Nd: YAG laser source of 7 ns pulse, 532 nm wavelength adjusted to the same total dose as in the case of CW laser irradiation set of experiments (30 mJ/cm2/ pulse, 100 pulses per minute). In the work, an 7-fold increase of chemical quenching was observed, indicative of a significantly higher rate of 1 O2 production [19]. The evidence of producing 1 O2 by irradiating GNPs were found with CW and pulsed laser sources. Two distinct pathways of 1 O2 production are involved during GNPs irradiation: i) A plasmon activated pathway that proceeds by the interactions of plasmons and hot electrons with molecular oxygen; ii) An indirect photo thermal pathway more pronounced in the case of GNPs irradiation with pulsed laser sources that induces extreme heat development leading to particle fragmentation and increased thermionic electron emission. As a result, 1 O2 and ROS generation is more efficient during irradiation with pulsed laser sources compared to the irradiation with CW lasers. Pulsed laser contributes significantly to the overall cancer cell death rates during photo thermal laser treatment [19].

GNPs are able to quickly convert the absorbed energy into heat energy in the picosecond time domain, making them excellent agents for hyperthermic cancer treatment [90]. In microbubble formation, as the bubble grows, the vapor cools and condenses. The bubble cannot sustain itself and implodes [11]. The lifetime of the bubble is a function of its size at maximal expansion [85]. Huang et al trigger apoptosis of cancer cells by manipulating the energy fluence. When the laser power density is high, GNPs fragmented results in localized mechanical shock to the cell membrane causing membrane perforation. At a low power, when the energy fluence is high enough, the heat produced from gold nanorods can also burn the cell membrane. These two effects will compromise the integrity and cause leaking of cell membrane, leading to rapid cell death by necrosis [41]. A gold nanoparticle creates responses in cells by all the possible mechanism when hit with different wavelength, mode and fluence of laser. When we deal with the dark side of gold, GNPs were alone produce toxicity in cells. Butterworth et al showed that millimolar concentrations of 1.9 nm gold particles decreased cell viability by 30% in bovine aortic endothelial cells [90]. A recent in vivo study, Cho et al showed that 13 nm PEG-coated gold nanoparticles had significant in vivo toxicity causing acute inflammation and apoptosis in the livers of BALB/ c mice [90]. Conversely, Connor et al failed to show acute toxicity for cysteine and citrate capped 4 nm particles and 18 nm cetyl trimethyl ammonium bromide (CTAB) particles [90].

CW/Pulsed Laser?

The comparison made between CW and femtosecond pulsed laser by Tong et al., confirms that short-pulsed laser was more effective than CW laser [55]. The responses from cells as a function of the length of time through the irradiation area were revealed by Hong et al [60]. At a low laser pulse energy photo thermal responses were observed without cell damage; a fast-rising initial peak due to quick heating of the cell through absorption by cellular chromophores and a lower exponential tail corresponding to cell cooling as a whole through heat diffusion into the surrounding solution. Femtosecond laser micro-surgery (FLMS) has emerged as a superior technique for ablation of cells and subcellular structures radiation therapy. In FLMS, laser absorption is confined to the focal volume by nonlinear interaction. This technique has been used clinically for surgery since 2003. The combination of gold nanoparticles with FLMS can lead to the development of less invasive hyperthermia treatments [71]. Folate-GNRs showed the stronger thermolysis effect by fs-pulsed laser irradiation than CW laser due to the increased ultrafast electron dynamics involved in plasmonmediated heating [55]. Major advantage of photo nano medicine is surrounding cells are not affected as in other modes of therapy. Designing fibre coupled laser and selecting wide laser source for nanoparticle helps photo nano therapy to advanced levels for invasive and non-invasive treatment for cancer. Lasers are advantageous over other irradiation sources since the noninvasiveness and availability in selected wavelengths minimize laser application in cancer therapy. As an alternate, light-emitting diodes (LEDs)—a monochromatic noncoherent low-power light source may be used. LEDs along with GNP have its own merits that provide therapeutic benefits of PPT when compared to lasers. Prof. Tina Karu states that the coherence of light is of no importance in low-power laser clinical effects [90]. Light Emitting Diode (LED) found to be an alternate for LASER in PPT.A comparison between LED and Laser of 530 nm and 532 nm wavelengths were used as irradiation source in normal cell lines with same fluency. Cells incubated with GNP and irradiated with LED and laser (Figure 5).

 Portable green and red LED designed for 96 well plate. Wavelength spectra of green LED and red LED (top)

Figure 5 Portable green and red LED designed for 96 well plate. Wavelength spectra of green LED and red LED (top).

Apoptotic bodies were developed in both cases and the surrounding cells were intact [90]. Fibre coupled LEDs can be used for in vivo applications. In superficial tissues multiple LED can be used simultaneously and design the source based on the application requirement. LED is monochromatic non-coherent light source and can easily fiber coupled to reach the deep-seated tissues and was available in all wavelength range.

By the power and precision, lasers are well suited for cancer surgery and medicine; by portable, easy to make fibre coupled devices, economic, wavelength independent properties, LED also seed attention as an irradiation source. When cancer surgeons start to use lasers, as well as when lasers become smaller and cheaper and technology improves to reach deep-seated cancer, lasers may become regular practice for cancer treatment. Thorough knowledge in cellular mechanism helps to brighten cancer therapeutics with non ionizing radiation.

ACKNOWLEDGEMENTS

I would like to thank Mr. Sundaresan Swaminathan my husband, for extending his support for making this review article.

REFERENCES

1. Abdel-Kader MH. Photodynamic Therapy: From Theory to Application (Text book). 2014.

2. Repacholi MH, McLennan G, Pugatschew A, Hancock R. Current and future application of laser in medicine, light laser and synchronous radaiation. Springer science. 1991.

3. Laakso L, Richardson C, Cramond T. Quality of light - is laser necessary for effective photobiostimulation? Aust J Physiother. 1993; 39: 87-92.

4. Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci. 2008; 23: 217-228.

5. Arruebo M, Vilaboa N, Sáez-Gutierrez B, Lambea J, Tres A, Valladares M, et al. Assessment of the evolution of cancer treatment therapies. Cancers (Basel). 2011; 3: 3279-3330.

6. Takac S, Stojanovi? S, Muhi B. [Types of medical lasers]. Med Pregl. 1998; 51: 146-150.

7. Martin P. The light of life. The Rotarian. 1987.

8. Bashkatov AN, Genina EA, Tuchin VV. Quantification of tissue optical properties: perspectives for precise optical diagnostics, phototherapy and laser surgery. J Phys D Appl Phys. 2016; 49: 50100.

9. Grossweiner LI, Linda JI, James BG, Gerald BHR. The Science of Phototherapy: An Introduction. Springer publications (Text Book).

10. Ravindra K Pandey, David Kessel, Thomas J Dougherty, Handbook of Photodynamic Therapy: Updates on Recent Applications of porphyrin based compounds, World scientific publications(Text Book)

11. Pitsillides CM, Joe EK, Wei X, Anderson RR, Lin CP. Selective cell targeting with light-absorbing microparticles and nanoparticles. Biophys J. 2003; 84: 4023-4032.

12. C P Lin, M W Kelly, S A B Sibayan, M A Latina, and R R Anderson. 1999. Selective cell killing by microparticle absorption of pulsed laser radiation. IEEE J. Quant. Electr. 5:963-968.

13. Mochalin VN, Shenderova O, Ho D, Gogotsi Y. The properties and applications of nanodiamonds. Nat Nanotechnol. 2011; 7: 11-23.

14. Lombard J, Biben T, Merabia S. Ballistic heat transport in laser generated nano-bubbles. Nanoscale. 2016; 8: 14870-14876.

15. B Erin Dickerson,CErik Dreadenb, Xiaohua Huang, Ivan H ElSayed, Hunghao Chu, Sujatha Pushpanketh, John F. McDonald, and Mostafa A. El-Sayed, Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice, Cancer Lett. 2008 September 28; 269(1): 57-66. doi:10.1016/j. canlet.2008.04.026.

16. V P Zharov, R R Letfullin, and E N Galitovskaya. Microbubblesoverlapping mode for laser killing of cancer cells with absorbing nanoparticle clusters. J. Phys. D: Appl. Phys. 2005; 38:2571-2581 doi:10.1088/0022-3727/38/15/007.

17. Daniel S. Wagner, Nikki A. Delk, Ekaterina Y. Lukianova-Hleb, Jason H. Hafner,Mary C. Farach-Carson, and Dmitri O. Lapotko, The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts, Biomaterials,2010 Oct; 31(29): 7567-7574.doi: 10.1016/j.biomaterials.2010.06.031.

18. Shih-Hsun Cheng, Chia-Hung Lee, Chung-Shi Yang, Fan-Gang Tseng, Chung-Yuan Moud Leu-Wei Lo, Mesoporous silica nanoparticles functionalized with an oxygen-sensing probe for cell photodynamic therapy: potential cancer theranostics. J. Mater. Chem. 2009; 19: 1252-1257

19. Huang P, Xu C, Lin J, Wang C, Wang X, Zhang C, et al. Folic Acidconjugated Graphene Oxide loaded with Photosensitizers for Targeting Photodynamic Therapy. Theranostics. 2011; 1: 240-250.

20. Singh AK, Hahn MA, Gutwein LG, Rule MC, Knapik JA, Moudgil BM, et al. Multi-dye theranostic nanoparticle platform for bioimaging and cancer therapy. Int J Nanomedicine. 2012; 7: 2739-2750.

21. Shouyan Wang J, Gwangseong Kim, Yong-Eun Koo Lee, Hoe Jin Hah, Manivannan Ethirajan, Ravindra K. Pandey et al. Multifunctional Biodegradable Polyacrylamide Nano carriers for Cancer Theranostics – A See and Treat Strategy.

22. Nam J, Won N, Jin H, Chung H, Kim S. pH-Induced aggregation of gold nanoparticles for photothermal cancer therapy. J Am Chem Soc. 2009; 131: 13639-13645.

23. Shouyan Wang, Wenzhe Fan, Gwangseong Kim, Hoe Jin Hah, YongEun Koo Lee, Raoul Kopelman et al, Novel Methods to Incorporate Photosensitizers Into Nano carriers for Cancer Treatment by Photodynamic Therapy. Lasers Surg Med. 2011; 43(7): 686-695. Doi: 10.1002/lsm.21113.

24. Tymish Y Ohulchanskyy, Indrajit Roy, Lalit N Goswami, Yihui Chen, Earl J Bergey, Ravindra K Pandey et al. Organically Modified Silica Nanoparticles with Covalently Incorporated Photosensitizer for Photodynamic Therapy of Cancer. Nano Lett. 2007; 7 (9): 2835-2842. DOI: 10.1021/nl0714637

25. Jon R Whitney, Saugata Sarkar, Jianfei Zhang, Thao Do, Taylor Young, Mary Kyle Manson et al. Single Walled Carbon nanohorns as Photo thermal Cancer Agents. Lasers in Surgery and Medicine. 2011; 43:43- 51.

26. Kyung Hyun Min Kyeongsoon Park, Yoo Shin Kim, Sang Mun Bae, Seulki Lee, Hyung Gon Jo, Rang-Woon Park In-San Kim Seo Young Jeong et al. Hydrophobically modified glycol chitosan nanoparticlesencapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. Jour.of Controlled Release. 2008; 127; 208-218

27. Jing Shouju Wang, Peng Huang, Zhe Wang, Shouhui Chen, Gang Niu, Wanwan Li et al. Photosensitizer-Loaded Gold Vesicles with Strong Plasmonic Coupling Effect for Imaging-Guided Photothermal/ Photodynamic Therapy. ACS Nano. 2013; 7(6): 5320-5329. Doi: 10.1021/nn4011686.

28. Mallick S, Sun IC, Kim K, Yil DK. Silica coated gold nanorods for imaging and photo-thermal therapy of cancer cells. J Nanosci Nanotechnol. 2013; 13: 3223-3229.

29. Shouju Wang et al, Single Continuous Wave Laser Induced Photodynamic/ Plasmonic Photo thermal Therapy Using Photosensitizer- Functionalized Gold Nano stars. Adv Mater. 2013; 25(22): 3055-3061. Doi:10.1002/adma.201204623.

30. Dreaden EC, Austin LA, Mackey MA, El-Sayed MA. Size matters: gold nanoparticles in targeted cancer drug delivery. Ther Deliv. 2012; 3: 457-478.

31. Peng Huang Jing Lina Shouju Wang, Zhijun Zhou, Zhiming Li, Zhe Wang, Chunlei Zhang, Xuyi Yue. Photosensitizer-Conjugated Silica-Coated Gold Nanoclusters for Fluorescence Imaging-Guided PhotodynamicTherapy.Biomaterials.2013;34(19):4643-4654.Doi: 10.1016/j.biomaterials.2013.02.063.

32. Pengfei Rong Kai Yang, Avinash Srivastan, Dale O. Kiesewetter, Xuyi Yue Fu Wang, Liming Nie, Ashwin kumar Bhirde et al. Photosensitizer Loaded Nano-Graphene for Multimodality Imaging Guided Tumor Photodynamic Therapy. Theranostics. 2014; 4: 3.

33. So Jin Lee Heebeom Koo, Hayoung Jeong, Myung Sook Huh Yongseok Choi Seo Young Jeong Youngro Byun Kuiwon Choi, Kwangmeyung Kim Ick Chan Kwon. Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy. Journal of Controlled Release. 2011; 152: 21-29.

34. Martina E Wieder, Duncan C Hone, Michael J Cook, Madeleine M Handsley, Jelena Gavrilovicb and David A Russell. Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a Trojan horse Photochem. Photobiol. Sci. 2006; 5: 727-734.

35. Bieke Van de Broek, Nick Devoogdt, Antoine DHollander, HannahLaura Gijs, Karolien Jans, Liesbet Lagae Serge Muyldermans. Specific Cell Targeting with Nanobody Conjugated Branched Gold Nanoparticles for Photothermal Therapy 5; 6: 4319-4328.

36. Li JL, Gu M. Surface plasmonic gold nanorods for enhanced twophoton microscopic imaging and apoptosis induction of cancer cells. Biomaterials. 2010; 31: 9492-9498.

37. Ganesh Gollavelli, Yong-Chien Ling. Magnetic and fluorescent graphene for dual modal imaging and single light induced photo thermal and photodynamic therapy of cancer cells. Biomaterials. 2014; 35: 4499-4507

38. Pitsillides CM, Joe EK, Wei X, Anderson RR, Lin CP. Selective cell targeting with light-absorbing microparticles and nanoparticles. Biophys J. 2003; 84: 4023-4032.

39. Lule Beqa, Zhen Fan, Anant Kumar Singh, Dulal Senapati, and Paresh Chandra Ray. Gold Nano Popcorn Attached SWCNT Hybrid Nanomaterial for Targeted Diagnosis and Photothermal Therapy of Human Breast Cancer Cells. ACS Appl Mater Interfaces. 2011; 3(9): 3316-3324. Doi: 10.1021/am2004366.

40. Gao L, Fei J, Zhao J, Li H, Cui Y, Li J. Hypocrellin-loaded gold nanocages with high two-photon efficiency for photothermal/photodynamic cancer therapy in vitro. ACS Nano. 2012; 6: 8030-40.

41. Yu-Fen Huang, Kwame Sefah, Suwussa Bamrungsap, Huan-Tsung Chang, Weihong Tan. ?Selective Photothermal Therapy for Mixed Cancer Cells Using Aptamer-Conjugated Nanorods. Langmuir. 2008; 24: 11860-11865.

42. Chen J, Glaus C, Laforest R, Zhang Q, Yang M, Gidding M, et al. Gold nanocages as photothermal transducers for cancer treatment. Small. 2010; 6: 811-817.

43. Zonghai Sheng, Liang Song, Jiaxiang Zheng, Dehong Hu, Meng He,?Mingbin Zheng. Protein-assisted fabrication of nano-reduced graphene oxide for combined in vivo photoacoustic imaging and photothermal therapy. Biomaterials. 2013; 34 : 5236-5243.

44. Choi WI, Sahu A, Kim YH, Tae G. Photothermal cancer therapy and imaging based on gold nanorods. Ann Biomed Eng. 2012; 40: 534-546.

45. Fernandez Cabada T, Sanchez Lopez de Pablo C, Martinez Serrano A, del Pozo Guerrero F, Serrano Olmedo JJ, Ramos Gomez M. Induction of cell death in a glioblastoma line by hyperthermic therapy based on gold nanorods. Int J Nanomedicine. 2012; 7: 1511-1523.

46. Erin B. Dickerson, Erik C. Dreaden, Xiaohua Huang, Ivan H. El-Sayed, Hunghao Chu, Sujatha Pushpanketh et al. Gold nanorod assisted nearinfrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett. 2008 269(1): 57-66. doi:10.1016/j. canlet.2008.04.026.

47. Juan Li, Fei Jiang, Bo Yang, Xiao-Rong Song, Yan Liu, Huang-Hao Yang. Topological insulator bismuth selenide as a theranostic platform for simultaneous cancer imaging and therapy. Sci. Rep.1998; 3: DOI:10.1038/ srep01998.

48. Lei Wang, Synergistic enhancement of cancer therapy using?a combination of docetaxel and photothermal ablation induced by single-walled carbon nanotubes. International Journal of Nanomedicine 2011:6 2641-2652.

49. Gil Gonalves, Mercedes Vila, Mara-Teresa Portols, Mara Vallet-Regi, Jos Gracio, and Paula Alexandrina A. P. Marques. Nano-Graphene Oxide: A Potential Multifunctional Platform for Cancer Therapy. Adv. Healthcare Mater. 2013; 2:1072-1090.

50. Andr M. Gobin, Emily M. Watkins, Elizabeth Quevedo, Vicki L. Colvin, and Jennifer L. West. Near Infrared Resonant Gold / Gold Sulfide Nanoparticles as a Photothermal Cancer Therapeutic Agent. Small. 2010. 6(6); 745-752. doi:10.1002/smll.200901557.

51. Joshua T. Robinson, Kevin Welsher, Scott M. Tabakman, Sarah P. Sherlock, Hailiang Wang, Richard Luong, and Hongjie Dai. Imaging and Photothermal Cancer Therapy with Carbon Nanotubes. Nano Res. 2010; 3(11): 779-793. Doi:10.1007/s12274-010-0045.

52. Cheng L, Yang K, Chen Q, Liu Z. Organic stealth nanoparticles for highly effective in vivo near-infrared photothermal therapy of cancer. ACS Nano. 2012; 6: 5605-5613.

53. Wen Zhang, Zhouyi Guo, Deqiu Huang, Zhiming Liu, Xi Guo, Huiqing Zhong. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials.2011; 32 : 8555-8561.

54. Lijia Jing, Xiaolong Liang, Zijian Deng, Shanshan Feng, Xiaoda Li, Maomao Huang et al. Prussian blue coated gold nanoparticles for simultaneous photoacoustic/CT bimodal imaging and photothermal ablation of cancer. Biomaterials. 2014; 35: 5814-5821.

55. Kai Yang, Shuai Zhang, Guoxin Zhang, Xiaoming Sun, Shuit-Tong Lee, Zhuang Liu. Graphene in Mice: Ultrahigh In Vivo Tumor Uptake and Efficient Photothermal Therapy. Nano Lett. 2010; 10:3318-3323.DOI: 10.1021/nl100996u |.(R91)

56. Feng Y, Fuentes D, Hawkins A, Bass J, Rylander MN, Elliott A, et al. Nanoshell-mediated laser surgery simulation for prostate cancer treatment. Eng Comput. 2009; 25: 3-13.

57. Liu H, Liu T, Wu X, Li L, Tan L, Chen D, et al. Targeting gold nanoshells on silica nanorattles: a drug cocktail to fight breast tumors via a single irradiation with near-infrared laser light. Adv Mater. 2012; 24: 755- 761.

58. Yin W, Yan L, Yu J, Tian G, Zhou L, Zheng X, et al. High-throughput synthesis of single-layer MoS2 nanosheets as a near-infrared photothermal-triggered drug delivery for effective cancer therapy. ACS Nano. 2014; 8: 6922-6933.

59. Li Y, Lu W, Huang Q, Huang M, Li C, Chen W. Copper sulfide nanoparticles for photothermal ablation of tumor cells. Nanomedicine (Lond). 2010; 1161-1171.

60. Hong C, Lee J, Zheng H, Hong SS, Lee C. Porous silicon nanoparticles for cancer photothermotherapy. Nanoscale Res Lett. 2011; 6: 321.

61. Huang-Chiao Huang, Kaushal Rege, and Jeffrey J. Heys. Spatiotemporal Temperature Distribution and Cancer Cell Death in Response to Extracellular Hyperthermia Induced by Gold Nanorods. ACS Nano. 2010 4(5): 2892-2900. doi:10.1021/nn901884d.

62. Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc. 2006; 128: 2115-2120.

63. Chen CL, Kuo LR, Lee SY, Hwu YK, Chou SW, Chen CC, et al. Photothermal cancer therapy via femtosecond-laser-excited FePt nanoparticles. Biomaterials. 2013; 34: 1128-1134.

64. Andr M. Gobin, Emily M. Watkins, Elizabeth Quevedo, Vicki L. Colvin, and Jennifer L. West, Near Infrared Resonant Gold / Gold Sulfide Nanoparticles as a Photothermal Cancer Therapeutic Agent Small. 2010;6(6): 745-752. doi:10.1002/smll.200901557.

65. ACS Leslie Au, Desheng Zheng, Fei Zhou, Zhi-Yuan Li, Xingde Li and Younan Xia. A Quantitative Study on the Photothermal Effect of Immuno Gold Nanocages Targeted to Breast Cancer Cells. Nano. 2008; 2(8): 1645-1652. doi:10.1021/nn800370j. Beike Wang, Jia-Hong Wang, Qian Liu, Hao Huangb, Ming Chen, Kaiyang Li.Rose-bengalconjugated gold nanorods for in vivo photodynamic and photothermal oral cancer therapies. Biomaterials. 2014; 35 1954-1966.

66. Ekaterina Y. Lukianova-Hle, Andrey Belyanin, Shruti Kashinath, Xiangwei Wu, and Dmitri O. Lapotko.Plasmonic nanobubble-enhanced endosomal escape processes for selective and guided intracellular delivery of chemotherapy to drug-resistant cancer cells. Biomaterials. 2012; 33(6): 1821-1826. doi:10.1016/j.biomaterials.2011.11.015.

67. Ekaterina Y. Lukianova-Hleb. Plasmonic nanobubbles enhance efficacy and selectivity of chemotherapy against drug-resistant cancer cells. Adv Mater. 2012; 24(28): 3831-3837. doi:10.1002/adma.201103550.

68.Yang J, Lee J, Kang J, Oh SJ, Ko HJ, Son JH, et al. Smart drug-loaded polymer gold nanoshells for systemic and localized therapy of human epithelial cancer. Adv Mater. 2009; 21: 4339-4342.

69. Qiwei Tian, Feiran Jiang, Rujia Zou, Qian Liu, Zhigang Chen, Meifang Zhu.Hydrophilic Cu9S5 Nanocrystals: A Photothermal Agent with a 25.7% Heat Conversion Efficiency for Photothermal Ablation of Cancer Cells in Vivo. 2011; 5 : 12 9761-9771.

70. Zhou F, Wu S, Wu B, Chen WR, Xing D. Mitochondria-targeting singlewalled carbon nanotubes for cancer photothermal therapy. Small. 2011; 7: 2727-35.

71. Wang X, Meng G, Zhang S, Liu X. A Reactive (1)O2 - Responsive Combined Treatment System of Photodynamic and Chemotherapy for Cancer. Sci Rep. 2016 Jul 22;6:29911. doi: 10.1038/srep29911.

72. V P Zharov, R R Letfullin, and E N Galitovskaya. Microbubblesoverlapping mode for laser killing of cancer cells with absorbing nanoparticle clusters. J. Phys. D: Appl. Phys. 2005; 38:2571-2581

73. Baozhong Zhao, Jun-Jie Yin, Piotr J. Bilski, Colin F. Chignell, Joan E. Roberts, and Yu-Ying He. Enhanced Photodynamic Efficacy towards Melanoma Cells by Encapsulation of Pc4 in Silica Nanoparticles. Toxicol Appl Pharmacol. 2009 ; 241(2): 163-172. doi:10.1016/j. taap.2009.08.010.

74. Daniel S. Wagner, Nikki A. Delk, Ekaterina Y. Lukianova-Hleb, Jason H. Hafner, Mary C. Farach-Carson, and Dmitri O. Lapotko. The in vivo performance of plasmonic nano bubbles as cell theranostic agents in zebra fish hosting prostate cancer xenografts. Biomaterials. 2010; 31(29): 7567-7574. Doi: 10.1016/j.biomaterials.20 10.06.031.

75. Jing Liang Li, Daniel Day, and Min Gu. Ultra-Low Energy Threshold for Cancer Photo thermal Therapy Using Transferrin-Conjugated Gold Nanorods. Adv. Mater. 2008; 20: 3866-13871.

76. Zhenjiang Zhang, Liming Wang, Jing Wang, Xiumei Jiang, Xiaohui Li, Zhijian Hu. Mesoporous Silica-Coated Gold Nanorods as a LightMediated Multifunctional Theranostic Platform for Cancer Treatment Adv. Mater. 2012; 24: 1418-1423.

77. Pawel Mroz, Anna Pawlak, Minahil Satti, Haeryeon Lee, Tim Wharton, Hariprasad Gali. Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism. Free Radic Biol Med. 2007; 43(5): 711-719.

78. Pawel Mroz, Anna Pawlak, Minahil Satti, Haeryeon Lee, Tim Wharton, Hariprasad Gali et al. Novel multifunctional PHDCA/PEI nano-drug carriers for simultaneous magnetically targeted cancer therapy and diagnosisvia magnetic resonance imaging. Nanotechnology. 2007; 18 : 475105 doi:10.1088/0957-4484/18/47/475105

79. Santra S, Kaittanis C, Grimm J, Perez JM. Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging. Small. 2009; 5: 1862-1868. 

80. Wang Y, Chen J, Irudayaraj J. Nuclear targeting dynamics of gold nanoclusters for enhanced therapy of HER2+ breast cancer. ACS Nano. 2011; 5: 9718-9725.

81. Rapoport N, Kennedy AM, Shea JE, Scaife CL, Nam KH. Ultrasonic nanotherapy of pancreatic cancer: lessons from ultrasound imaging. Mol Pharm. 2010; 7: 22-31.

82. Srivalleesha Mallidi, Geoffrey P. Luke, and Stanislav Emelianov. Photoacoustic imaging in cancer detection, diagnosis, and treatment guidance. Trends Biotechnol. 2011; 29(5): 213-221. doi:10.1016/j. tibtech.2011.01.006.

83. K T Butterworth, J A Coulter, S Jain, J Forker, S J McMahon, G Schettino, K M Prise, F J Currell, and D G Hirst. Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy. Nanotechnology. 2010 ; 21(29): 295101. doi:10.1088/0957-4484/21/29/295101.

84. Tuan Hiep Tran, Hanh Thuy Nguyen, Tung Thanh Pham, Ju Yeon Choi, Han-Gon Choi, Chul Soon Yong, and Jong Oh Kim,Development of a Graphene Oxide Nanocarrier for Dual-Drug Chemo-phototherapy to Overcome Drug Resistance in CancerACS Appl. Mater. Interfaces, 2015, 7 (51), pp 2864728655 DOI: 10.1021/acsami.5b1042

85. Mochalin VN1, Shenderova O, Ho D, Gogotsi Y. The properties and applications of nanodiamonds. Nat Nanotechnol. 2011; 7: 11-23.

86. Jingwei Shao, Robert J. Griffin, Ekaterina I. Galanzha, Jin-Woo Kim,Nathan Koonce, Jessica Webber, Thikra Mustafa,Alexandru S. Biris,Dmitry A. Nedosekin, and Vladimir P. Zharova,2Photothermal nanodrugs: potential of TNF-gold nanospheres for cancer theranostics

87. Jingwei Shao, Robert J. Griffin, Ekaterina I. Galanzha, Jin-Woo Kim, Nathan Koonce, Jessica Webber, Thikra Mustafa, Alexandru S. Biris, Dmitry A. Nedosekin, and Vladimir P. Zharova,Photothermal nanodrugs: potential of TNF-gold nanospheres for cancer theranostics

88. Liu, Y., Zhang, J., Zuo, C. et al. Nano Res. (2016) 9: 3257. doi:10.1007/ s12274-016-1204-9

89. Poorani Gananathan, Aruna Prakasa Rao, Ganesan Singaravelu, and Elanchezhiyan Manickam,Post Irradiation Effect of Gold Nanoparticles and Low Power Laser in MDCK Cells, J. Bionanosci. 2016, Vol. 10.

90. Huff TB, Tong L, Zhao Y, Hansen MN, Cheng JX, Wei A. Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine (Lond). 2007; 125-132.

91. K T Butterworth, J A Coulter, S Jain, J Forker, S J McMahon, G Schettino, K M Prise, F J Currell, and D G Hirst, Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy, Nanotechnology. 2010 Jul 23; 21(29): 295101.doi: 10.1088/0957-4484/21/29/295101

92. Cho WS, Cho M, Jeong J, Choi M, Cho HY, Han BS, et al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol. 2009; 236: 16-24.

93. Poorani Gananathan, Aruna PrakasaRao and Ganesan Singaravelu, Elanchezhiyan Manickam,Plasmonic phototherapy of gold nanoparticles with Light Emitting Diode, International Journal of Biomedical Research.DOI (2016)2455-0566 10.7439/ijbr.

 

Gananathan P, Rao AP, Singaravelu G, Manickam E (2017) Review of Laser in Nanophotonics – A Literature Study for Cellular Mechanism. J Cancer Biol Res 5(1): 1094.

Received : 19 Dec 2016
Accepted : 19 Jan 2017
Published : 21 Jan 2017
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X